“psychotropic medications and children: science, law, and policy” uc hastings college of law...

27
“Psychotropic medications and children: science, Law, and Policy” UC Hastings college of law symposium on children’s health, mental health & the law March 29, 2014 3/29/14 Bill Grimm 1

Upload: barnard-mitchell

Post on 25-Dec-2015

215 views

Category:

Documents


1 download

TRANSCRIPT

Bill Grimm 1

“Psychotropic medications and children: science, Law, and Policy”

UC Hastings college of law symposium on children’s health, mental health & the law

March 29, 2014

3/29/14

Bill Grimm 2

Federal Focus & Action

Court Resolution & The JV220 Process

State Initiatives

Psychotropic Drug Concerns

Standard of Care

Prioritizing Policies & Actions

Improving Prescribing Practices

3/29/14

Federal Focus and Action

February 2006: Senate Finance Committee TestimonyOctober 2008: Federal Fostering Connections to Success and Increasing

Adoptions ActSeptember 2011: Child and Family Services Improvement and Innovation ActNovember 2011: Joint Letter from ACF, CMS, SAMHSA, HHS December 2011: GAO Report Foster Children April 2012: Children’s Bureau Information MemorandumAugust 2012: ACF Because Minds Matter ConferenceDecember 2012: GAO Report Children’s Mental HealthAugust 2013: HHS Office of the Inspector General InvestigationMarch 2013: The President’s Budget - $750 million

3/29/14 Bill Grimm 3

Federal Focus and Action“I think putting me on all these stupid meds was the most idiotic thing I have ever experienced in foster care and was the worst thing someone could do to foster kids. I was upset about my situation, not bipolar or ADHD.”

Testimony of Ke’onte Cooke, 12 year old former foster child, before Congress, December 1, 2011

3/29/14Bill Grimm

4

Bill Grimm 5

Court Resolution & The JV220 Process

National Council of Juvenile & Family Court Judges Resolution

Whereas, Judges in child welfare and juvenile justice cases are responsible for overseeing the safety and well-being of children under court jurisdiction;

Whereas, the NCJFCJ believes that this oversight responsibility extends to children prescribed psychotropic medications, including ensuring that medications are safe and appropriate…

3/29/14

6

Court Resolution & The JV220 Process

JV-220 Process

• Statute enacted in 1999• Intended to reduce use

of psychotropic drugs

Is the Court Review & Authorization Process effective?

3/29/14Bill Grimm

Bill Grimm 7

% % % % % % %JUL2006-SEP2006

JUL2007-SEP2007

JUL2008-SEP2008

JUL2009-SEP2009

JUL2010-SEP2010

JUL2011-SEP2011

JUL2012-SEP2012

13.1 13.1

15.817.8 18.6 18.8 19.4

Percentage of Children in Care Authorized Psychotropic Med-ications

2006-2012

3/29/14

COURT RESOLUTION & THE JV220 PROCESS

Bill Grimm 8

Pre-

Adop

t

Kin

Fost

er

FFA

Cour

t Spe

cifie

d

Gro

up

Shel

ter

Tran

sitio

nal H

ousi

ng

Gua

rdia

n-D

epen

dent

Runa

way

Tria

l Hom

e Vi

sit

Oth

er

Mis

sing

Placement Type All

0

10

20

30

40

50

60

12.79.4

25

16

29.8

56

31.1

22 19.527.3

8.7

20 19.9 19.4

Percentage of Children Authorized Psychotropic Medications By Placement TypeApr-Jun 2013

3/29/14

COURT RESOLUTION & THE JV220 PROCESS

Bill Grimm 9

COURT RESOLUTION & THE JV220 PROCESS

3/29/14

San Francisco Contra Costa Los Angeles State

18.50%

9.10%

13.10% 12.60%

Percentage of California Foster Children Au-thorized Psych Drugs

% Authorized Psych Drugs

Anna Johnson 10

State Initiatives September 2010: AB 12 Passed

August 2012: Because Minds Matter ConferenceOctober 2012: Quality Improvement Project Charter Kick-off January 2012: “Monthly” Workgroup Calls

Clinical WorkgroupData and Technology Workgroup

Youth, Family and Education Workgroup

August 2013: Draft Action Plan CirculatedSeptember 2013-February 2014: State Process SuspendedFebruary 26th, 2014: Invitation Only Meeting

March 26th, 2014: Meeting to Kick-off Workgroups

10/21/13

Bill Grimm 11

Psychotropic Drug ConcernsToo ManyToo Much Too SoonToo Long No Monitoring (Mis- Over- Inaccurate) DiagnosesNo Risk/Benefit ProfilesUntestedOff-labelNo AlternativesAdverse EffectsPowerful OppositionUntrained CaregiversLack of educational resources

3/29/14

Bill Grimm 12

Too Many• Children in care

medicated• Children on multiple

medications• Inaccurate

diagnoses

3/29/14

ABC News Investigation

Psychotropic Drug Concerns

Bill Grimm 13

Too Much• Above maximum

dosages• Adult dosages for

children

3/29/14

Gabriel Myers Story

Psychotropic Drug Concerns

Bill Grimm 14

Too Soon• Very young ages• Too early in placement• Before other

interventions

3/29/14

Tiffany's Story

Psychotropic Drug Concerns

Bill Grimm 15

Too Long• No set monitoring• No timeline to taper

off• Authorization for

indefinite amount of time

3/29/14

Tristen's Story

Psychotropic Drug Concerns

Bill Grimm 16

Standard of Care

Policy Sources: Appropriate Use of PsychotropicsAmerican Academy of Child & Adolescent

Psychiatry (AACAP)Child Welfare League of America (CWLA)HEDISAmerican Academy of Pediatrics (AAP)State LegislationMedicaid Medical Directors Learning Network

(MMDLN)3/29/14

Bill Grimm 17

Prioritizing Policies & Actions

Special Populations

Very young children Child-bearing age youth Youth transitioning from

care Group home youth

3/29/14

Bill Grimm 183/29/14

Prioritizing Policies & Actions

Antipsychotics

Limited FDA approval Off-label prescription Adverse Effects Disruptive Behavior

Diagnoses

Bill Grimm 193/29/14

Maximum Dosing

LA Parameters Connecticut Guidelines

Prioritizing Policies & Actions

Bill Grimm 203/29/14

Prioritizing Policies & Actions

Polypharmacy

Bill Grimm 213/29/14

Prioritizing Policies & Actions

Gaps in Medications

Bill Grimm 22

Improving Prescribing Practices

Consultation & Second Review

CaliforniaChild PsychiatristsPublic Health NursesPharmacists

Minnesota Washington

3/29/14

Bill Grimm 23

Improving Prescribing Practices

Prior Authorizations/TARS

CA 2006 TAR for antipsychotic prescriptions for children under six

Prescriptions fell from 5686 to 4200

3/29/14

Bill Grimm 24

Improving Prescribing Practices

Monitoring Requirements & Baseline Metabolic

Testing

AK requires baseline lab testing and 9 month follow ups

NJ has a detailed monitoring protocol by drug class

3/29/14

Bill Grimm 25

Improving Prescribing Practices

Outlying Prescriber Identification

Many states use Medicaid pharmaceutical data to identify inappropriate prescribing patterns

3/29/14

Bill Grimm 26

Improving Prescribing Practices

Academic Detailing

Prescriber education and outreach

Safe Rx Amendment Act of 2008 established an academic detailing program in Washington, D.C.

3/29/14

Bill Grimm 27

Discussion and Questions

3/29/14

??

?